Effects of Ozone Therapy on Clinical Parameters and Inflammatory Cytokines in Chronic Periodontitis Patients

March 13, 2019 updated by: Sema Nur Sevinc, Ataturk University

Effects of Ozone Therapy Adjunct to Initial Periodontal Therapy on Clinical Parameters and Inflammatory Cytokines in Chronic Periodontitis Patients

The objective of this study is to evaluate of ozone therapy on both clinical and biochemical effects in periodontally patients.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

This study is evaluated clinical and biochemical effect of ozone therapy at 8 weeks in periodontitis patients.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • systemically healthy
  • non-smokers
  • chronic periodontitis participants

Exclusion Criteria:

  • smokers
  • pregnancy or lactation
  • individiuals with any systemic disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ozone therapy
control group only treated with Initial Periodontal Therapy (IPT), test group treated with IPT an adjunct to gasesos ozone therapy.
gaseous ozone was applied on periodontal pocket two times in one week.
Active Comparator: initially periodontal therapy
control group only treated with Initial Periodontal Therapy (IPT), test group treated with IPT an adjunct to gasesos ozone therapy.
gaseous ozone was applied on periodontal pocket two times in one week.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Probing of depth baseline
Time Frame: baseline (before treatment)
Measurement to the nearest millimeter from the gingival margin to the base of the clinical pocket by Williams periodontal probe
baseline (before treatment)
Clinical atachment level baseline
Time Frame: baseline (before treatment)
Calculation as distance in millimeters from cement-enamel junction to the bottom of the pocket by Williams periodontal probe
baseline (before treatment)
Plaque index baseline
Time Frame: baseline (before treatment)

As described by Silness&Löe 1964; The measurement of the state of oral hygiene by Silness-Löe plaque index is based on recording both soft debris and mineralized deposits on the following teeth. Each of the four surfaces of the teeth (buccal, lingual, mesial and distal) is given a score from 0-3.

Scores 0: No plaque. scores 1: A film of plaque adhering to the free gingival margin and adjacent area of the tooth. The plaque may be seen in situ only after application of disclosing solution or by using the probe on the tooth surface.

scores 2: Moderate accumulation of soft deposit s within the gingival pocket, or the tooth and gingival margin which can be seen with the naked eye.

scores 3: Abundance of soft matter within the gingival pocket and/or on the tooth and gingival margin.

score 0 considered good oral hygiene, score 3 bad oral hygiene habits. plaque index for a tooth=scores from 4 areas/4 plaque index individiual= scores from 28 tooth/28

baseline (before treatment)
Gingival index baseline
Time Frame: baseline (before treatment)

As described by Löe&Silness 1963; The bleeding is assessed by probing gently along the wall of soft tissue of the gingival sulcus. Each of the four surfaces of the teeth (buccal, lingual, mesial and distal) is given a score from 0-3.

score 0 - Normal, healthy gingival with sharp, non-inflamed margins. score 1 - Marginal gingivitis with minimal inflammation and edema at the free gingival. No bleeding on probing.

score 2 - Moderate gingivitis with a wider band of inflammation and bleeding upon probing.

score 3 - Advanced gingivitis with inflammation clinically reaching the mucogingival junction usually with ulceration.

score 0 considered healty gingiva, score 3 assesed advanced gingival disease. gingival index for a tooth=scores from 4 areas/4 gingival index individiual= scores from 28 tooth/28

baseline (before treatment)
Bleeding on probing baseline
Time Frame: baseline (before treatment)

As described by Ainamo&Bay 1975; The index is performed through gentle probing of the orifice of the gingival crevice. If bleeding occurs within 10 seconds a positive finding is recorded and the number of positive sites is recorded and then expressed as a percentage of the number of sites examined.

bleeding present (+) absent (-) bleeding surface/all surface *100=% bleeding absent recording is equivalent to gingival index scores 0&1. bleeding present recording is equivalent to gingival index score 2&3.

  • 0: no bleeding on probing, healty gingiva
  • 100: all gingiva bleeding on probing; diseased gingiva.
baseline (before treatment)
Biochemical outcomes baseline
Time Frame: baseline (before treatment)
In this study, biochemical parametres including IL-1B, IL-6, IL-10, TNF-a, MMP-9 were measured (pg/ml) by ELISA (Enzyme-Linked Immuno Sorbent Assay) measured (pg/ml) by ELISA (Enzyme-Linked Immuno Sorbent Assay) methods on Gingival Crevicular Fluid at baseline.
baseline (before treatment)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical attachment level after 8 weeks
Time Frame: 8 weeks after treatment
Calculation as distance in millimeters from cement-enamel junction to the bottom of the pocket by Williams periodontal probe
8 weeks after treatment
Plaque index after 8 weeks
Time Frame: 8 weeks after treatment

As described by Silness&Löe 1964; The measurement of the state of oral hygiene by Silness-Löe plaque index is based on recording both soft debris and mineralized deposits on the following teeth. Each of the four surfaces of the teeth (buccal, lingual, mesial and distal) is given a score from 0-3.

Scores 0: No plaque scores 1: A film of plaque adhering to the free gingival margin and adjacent area of the tooth. The plaque may be seen in situ only after application of disclosing solution or by using the probe on the tooth surface.

scores 2: Moderate accumulation of soft deposit s within the gingival pocket, or the tooth and gingival margin which can be seen with the naked eye.

scores 3: Abundance of soft matter within the gingival pocket and/or on the tooth and gingival margin.

score 0 considered good oral hygiene, score 3 bad oral hygiene habits. plaque index for a tooth=scores from 4 areas/4 plaque index individiual= scores from 28 tooth/28

8 weeks after treatment
Gingival index after 8 weeks
Time Frame: 8 weeks after tretament

As described by Löe&Silness 1963; The bleeding is assessed by probing gently along the wall of soft tissue of the gingival sulcus. Each of the four surfaces of the teeth (buccal, lingual, mesial and distal) is given a score from 0-3.

score 0 - Normal, healthy gingival with sharp, non-inflamed margins. score 1 - Marginal gingivitis with minimal inflammation and edema at the free gingival. No bleeding on probing.

score 2 - Moderate gingivitis with a wider band of inflammation and bleeding upon probing.

score 3 - Advanced gingivitis with inflammation clinically reaching the mucogingival junction usually with ulceration. score 0 considered healty gingiva, score 3 assesed advanced gingival disease.

gingival index for a tooth=scores from 4 areas/4 gingival index individiual= scores from 28 tooth/28

8 weeks after tretament
Bleeding on probing after 8 weeks
Time Frame: 8 weeks after treatment

As described by Ainamo&Bay 1975; the index is performed through gentle probing of the orifice of the gingival crevice. If bleeding occurs within 10 seconds a positive finding is recorded and the number of positive sites is recorded and then expressed as a percentage of the number of sites examined.

bleeding present (+) absent (-) bleeding surface/all surface *100=% bleeding absent recording is equivalent to gingival index scores 0&1. bleeding present recording is equivalent to gingival index score 2&3.

  • 0: no bleeding on probing, healty gingiva
  • 100: all gingiva bleeding on probing; diseased gingiva.
8 weeks after treatment
Probing of dept after 8 weeks
Time Frame: 8 weeks after tretament
Measurement to the nearest millimeter from the gingival margin to the base of the clinical pocket by Williams periodontal probe
8 weeks after tretament
Biochemical outcomes after 8 weeks
Time Frame: 8 weeks after tretment
In this study, biochemical parametres including IL-1B, IL-6, IL-10, TNF-a, MMP-9 were measured (pg/ml) by ELISA (Enzyme-Linked Immuno Sorbent Assay) measured (pg/ml) by ELISA (Enzyme-Linked Immuno Sorbent Assay) methods on Gingival Crevicular Fluid at 8 weeks
8 weeks after tretment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2014

Primary Completion (Actual)

October 1, 2015

Study Completion (Actual)

February 1, 2016

Study Registration Dates

First Submitted

May 1, 2016

First Submitted That Met QC Criteria

March 12, 2019

First Posted (Actual)

March 14, 2019

Study Record Updates

Last Update Posted (Actual)

March 15, 2019

Last Update Submitted That Met QC Criteria

March 13, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 60078

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe